Publicaciones en las que colabora con Emilio Martín Mola (20)

2016

  1. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 3-15

2015

  1. Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide

    Reumatologia Clinica, Vol. 11, Núm. 5, pp. 279-294

2013

  1. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 482-492

  2. El uso de abatacept en artritis reumatoide: Revisión de la evidencia y recomendaciones

    Reumatologia Clinica, Vol. 9, Núm. 1, pp. 5-17

2012

  1. Treating rheumatoid arthritis to target: Recommendations of an international task force

    Revmatologiia (Bulgaria), Vol. 20, Núm. 2, pp. 5-16

2011

  1. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 404-413

  2. American college of rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

    Arthritis and Rheumatism, Vol. 63, Núm. 3, pp. 573-586

  3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Revmatologiia, Vol. 19, Núm. 1, pp. 5-21

  4. Treating rheumatoid arthritis to target: Multinational recommendations assessment questionnaire

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 11, pp. 1999-2002

2010

  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 6, pp. 964-975

  2. Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression

    Reumatologia Clinica, Vol. 6, Núm. 1, pp. 63-68

  3. The Eular recommendations for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs

    Rheumatologia, Vol. 24, Núm. 4, pp. 143-158

  4. Treating rheumatoid arthritis to target: Recommendations of an international task force

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 4, pp. 631-637

2008

  1. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients withd-heumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1365-1373

  2. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1360-1364

  3. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

    Arthritis Care and Research, Vol. 59, Núm. 10, pp. 1371-1377

2007

  1. Consensus statement on the use of rituximab in patients with rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 66, Núm. 2, pp. 143-150

2006

  1. Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period

    Arthritis Research and Therapy, Vol. 8, Núm. 1

2000

  1. Consenso de la Sociedad de Reumatología sobre la terapia con inhibidores de TNF y otros fármacos inductores de remisió en la artritis reumatoide

    Revista Espanola de Reumatologia, Vol. 27, Núm. 8, pp. 352-354

1998

  1. Prospective study of serum and urinary nitrate levels in patients with systemic lupus erythematosus

    British Journal of Rheumatology, Vol. 37, Núm. 9, pp. 972-977